首页 > 最新文献

International Journal of Radiation Oncology Biology Physics最新文献

英文 中文
Heat or Healing? Dealing With “Something That Looks Like Progression” of Brain Metastases 热还是疗?处理脑转移“看起来像进展的东西”
IF 6.5 1区 医学 Q1 ONCOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-03 DOI: 10.1016/j.ijrobp.2025.12.002
Frank A. Giordano M.D.
{"title":"Heat or Healing? Dealing With “Something That Looks Like Progression” of Brain Metastases","authors":"Frank A. Giordano M.D.","doi":"10.1016/j.ijrobp.2025.12.002","DOIUrl":"10.1016/j.ijrobp.2025.12.002","url":null,"abstract":"","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"124 3","pages":"Page 572"},"PeriodicalIF":6.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ahead of the Curve: Early Recognition and Effective Management of Radiation Necrosis 超前:放射性坏死的早期识别和有效治疗
IF 6.5 1区 医学 Q1 ONCOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-03 DOI: 10.1016/j.ijrobp.2025.12.004
Christina Tsien MD, FRCP, FASTRO, Kevin Petrecca MD, PhD, FRSC
{"title":"Ahead of the Curve: Early Recognition and Effective Management of Radiation Necrosis","authors":"Christina Tsien MD, FRCP, FASTRO, Kevin Petrecca MD, PhD, FRSC","doi":"10.1016/j.ijrobp.2025.12.004","DOIUrl":"10.1016/j.ijrobp.2025.12.004","url":null,"abstract":"","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"124 3","pages":"Page 573"},"PeriodicalIF":6.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Reply to Oertel et al 在对Oertel等人的答复中
IF 6.5 1区 医学 Q1 ONCOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-03 DOI: 10.1016/j.ijrobp.2025.11.055
Christina C. Huang MD, Chris R. Kelsey MD
{"title":"In Reply to Oertel et al","authors":"Christina C. Huang MD, Chris R. Kelsey MD","doi":"10.1016/j.ijrobp.2025.11.055","DOIUrl":"10.1016/j.ijrobp.2025.11.055","url":null,"abstract":"","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"124 3","pages":"Pages 880-881"},"PeriodicalIF":6.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Too Hot to Handle? Navigating the Dilemma of Radiation Necrosis After Stereotactic Radiosurgery for Brain Metastases 太热了?脑转移瘤立体定向放射治疗后放射坏死的困境
IF 6.5 1区 医学 Q1 ONCOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-03 DOI: 10.1016/j.ijrobp.2025.10.032
Cas Stefaan Dejonckheere MD , Julian Philipp Layer MD
{"title":"Too Hot to Handle? Navigating the Dilemma of Radiation Necrosis After Stereotactic Radiosurgery for Brain Metastases","authors":"Cas Stefaan Dejonckheere MD , Julian Philipp Layer MD","doi":"10.1016/j.ijrobp.2025.10.032","DOIUrl":"10.1016/j.ijrobp.2025.10.032","url":null,"abstract":"","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"124 3","pages":"Pages 570-571"},"PeriodicalIF":6.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simultaneous Integrated Dose Reduction Radiation Therapy Versus Conventional Fractionated Radiation Therapy With Chemotherapy for Limited-Stage Small Cell Lung Cancer in the Modern Treatment Era: A Phase 3, Randomized Clinical Trial (SDR-RT trial) 在现代治疗时代,同步综合减剂量放疗与传统分割放疗联合化疗治疗有限期小细胞肺癌:一项III期随机临床试验(SDR-RT试验)
IF 6.5 1区 医学 Q1 ONCOLOGY Pub Date : 2026-03-01 Epub Date: 2025-10-14 DOI: 10.1016/j.ijrobp.2025.09.058
Tian-You Zhan MD , Tao Zhang MD , Wen-Qing Wang MD , Lei Deng MD , Yi-Rui Zhai MD , Wen-Bin Yan MD , Xin Wang MD , Jian-Yang Wang MD , Wen-Yang Liu MD , Ming-Hui Li PhD , Qin-Fu Feng MD , Ji-Ma Lv MD , Ze-Fen Xiao MD , Dong-Fu Chen MD , Jun-Ling Li MD , Lv-Hua Wang MD , Jun Liang MD , Hong Ge MD , Jian-Rong Dai PhD , Kuo Men PhD , Zong-Mei Zhou MD

Purpose

Simultaneous integrated dose reduction (SDR) radiation therapy (SDR-RT) with a definitive dose to the gross tumor volume (GTV) and a relatively lower dose to the clinical target volume (CTV) might be beneficial in improving normal tissue sparing with low toxicity. We aimed to compare the efficacies of SDR-RT and conventional fractionated radiation therapy (CF-RT) for limited-stage small cell lung cancer (LS-SCLC).

Methods and Materials

Eligible patients with LS-SCLC were 1:1 randomized to receive CF-RT (60 Gy in 30 once-daily fractions over 6 weeks for both CTV and GTV) or SDR-RT (50 Gy for CTV and 60 Gy for GTV in 28 once-daily fractions over 5.5 weeks) along with 4 to 6 cycles of chemotherapy. The primary endpoint was progression-free survival (PFS) rate in the intention-to-treat population, whereas the secondary endpoints were overall survival rate and adverse event incidence.

Results

Between February 2017 and March 2023, 336 patients randomly received either SDR-RT (n = 165) or CF-RT (n = 171). Over a median follow-up of 56 months, the 2- and 5-year PFS rates in the intention-to-treat analysis were, respectively, 42.0% and 31.9% with SDR-RT, and 40.7% and 30.5% with CF-RT (P = .015 for noninferiority). The between-group differences in overall survival, locoregional PFS, and locoregional recurrence rates were nonsignificant. Compared with CF-RT, SDR-RT was associated with lower median values of V20 (21.0% vs 22.8%) and Dmean (12.1 vs 13.4 Gy) of the bilateral lungs (both P < .001). Acute grade ≥3 toxicities and radiation pneumonitis incidence were lower with SDR-RT than that with CF-RT (54.5% vs 66.9%, P = .020; 2.4% vs 7.7%, P = .027).

Conclusions

Compared with CF-RT, SDR-RT led to similar survival and less acute adverse events. SDR-RT may be considered as a more protective approach for LS-SCLC treatment.
背景:同时综合减剂量(SDR)放疗(SDR- rt)对肿瘤总体积(GTV)的确定剂量和相对较低的临床靶体积(CTV)剂量可能有助于改善正常组织保留和低毒性。这项随机对照试验(SDR-RT试验)比较了SDR-RT和传统分割放疗(CF-RT)治疗有限期小细胞肺癌(LS-SCLC)的疗效。方法:符合条件的LS-SCLC患者以1:1的比例随机接受CF-RT (CTV和GTV每天30次,每次60 Gy,持续6周)或SDR-RT (CTV每天50 Gy, GTV每天28次,每次60 Gy,持续5.5周)以及4-6个周期的化疗。主要终点是意向治疗(ITT)人群的无进展生存(PFS)率,而次要终点是总生存(OS)率和不良事件发生率。结果:在2017年2月至2023年3月期间,336名患者随机接受了SDR-RT (n = 165)或CF-RT (n = 171)。在56个月的中位随访中,ITT分析的2年和5年PFS分别为SDR-RT组42.0%和31.9%,CF-RT组40.7%和30.5% (P = 0.015,非劣效性)。组间OS、局部区域PFS和局部区域复发率差异无统计学意义。与CF-RT相比,SDR-RT与双肺V20中位值(21.0%比22.8%)和Dmean(12.1比13.4 Gy)较低相关(P均< 0.001)。急性≥3级毒性反应和放射性肺炎发生率,SDR-RT组低于CF-RT组(54.5% vs 66.9%, P = 0.020;2.4% vs 7.7%, P = 0.027)。结论:与CF-RT相比,SDR-RT的生存期相似,急性不良事件较少。SDR-RT可能被认为是一种更具保护性的LS-SCLC治疗方法。试验注册:ClinicalTrials.gov, NCT04500145。
{"title":"Simultaneous Integrated Dose Reduction Radiation Therapy Versus Conventional Fractionated Radiation Therapy With Chemotherapy for Limited-Stage Small Cell Lung Cancer in the Modern Treatment Era: A Phase 3, Randomized Clinical Trial (SDR-RT trial)","authors":"Tian-You Zhan MD ,&nbsp;Tao Zhang MD ,&nbsp;Wen-Qing Wang MD ,&nbsp;Lei Deng MD ,&nbsp;Yi-Rui Zhai MD ,&nbsp;Wen-Bin Yan MD ,&nbsp;Xin Wang MD ,&nbsp;Jian-Yang Wang MD ,&nbsp;Wen-Yang Liu MD ,&nbsp;Ming-Hui Li PhD ,&nbsp;Qin-Fu Feng MD ,&nbsp;Ji-Ma Lv MD ,&nbsp;Ze-Fen Xiao MD ,&nbsp;Dong-Fu Chen MD ,&nbsp;Jun-Ling Li MD ,&nbsp;Lv-Hua Wang MD ,&nbsp;Jun Liang MD ,&nbsp;Hong Ge MD ,&nbsp;Jian-Rong Dai PhD ,&nbsp;Kuo Men PhD ,&nbsp;Zong-Mei Zhou MD","doi":"10.1016/j.ijrobp.2025.09.058","DOIUrl":"10.1016/j.ijrobp.2025.09.058","url":null,"abstract":"<div><h3>Purpose</h3><div>Simultaneous integrated dose reduction (SDR) radiation therapy (SDR-RT) with a definitive dose to the gross tumor volume (GTV) and a relatively lower dose to the clinical target volume (CTV) might be beneficial in improving normal tissue sparing with low toxicity. We aimed to compare the efficacies of SDR-RT and conventional fractionated radiation therapy (CF-RT) for limited-stage small cell lung cancer (LS-SCLC).</div></div><div><h3>Methods and Materials</h3><div>Eligible patients with LS-SCLC were 1:1 randomized to receive CF-RT (60 Gy in 30 once-daily fractions over 6 weeks for both CTV and GTV) or SDR-RT (50 Gy for CTV and 60 Gy for GTV in 28 once-daily fractions over 5.5 weeks) along with 4 to 6 cycles of chemotherapy. The primary endpoint was progression-free survival (PFS) rate in the intention-to-treat population, whereas the secondary endpoints were overall survival rate and adverse event incidence.</div></div><div><h3>Results</h3><div>Between February 2017 and March 2023, 336 patients randomly received either SDR-RT (n = 165) or CF-RT (n = 171). Over a median follow-up of 56 months, the 2- and 5-year PFS rates in the intention-to-treat analysis were, respectively, 42.0% and 31.9% with SDR-RT, and 40.7% and 30.5% with CF-RT (<em>P</em> = .015 for noninferiority). The between-group differences in overall survival, locoregional PFS, and locoregional recurrence rates were nonsignificant. Compared with CF-RT, SDR-RT was associated with lower median values of V20 (21.0% vs 22.8%) and Dmean (12.1 vs 13.4 Gy) of the bilateral lungs (both <em>P</em> &lt; .001). Acute grade ≥3 toxicities and radiation pneumonitis incidence were lower with SDR-RT than that with CF-RT (54.5% vs 66.9%, <em>P</em> = .020; 2.4% vs 7.7%, <em>P</em> = .027).</div></div><div><h3>Conclusions</h3><div>Compared with CF-RT, SDR-RT led to similar survival and less acute adverse events. SDR-RT may be considered as a more protective approach for LS-SCLC treatment.</div></div>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"124 3","pages":"Pages 692-701"},"PeriodicalIF":6.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145307933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Reply to Liu et al 回复刘等人
IF 6.5 1区 医学 Q1 ONCOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-03 DOI: 10.1016/j.ijrobp.2025.11.015
Pierre Loap MD, Youlia Kirova MD
{"title":"In Reply to Liu et al","authors":"Pierre Loap MD,&nbsp;Youlia Kirova MD","doi":"10.1016/j.ijrobp.2025.11.015","DOIUrl":"10.1016/j.ijrobp.2025.11.015","url":null,"abstract":"","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"124 3","pages":"Pages 877-878"},"PeriodicalIF":6.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating Tumor DNA in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma—Are We Ready to Individualize Treatment? 人乳头瘤病毒阳性口咽鳞状细胞癌循环肿瘤DNA -我们准备好个体化治疗了吗?
IF 6.5 1区 医学 Q1 ONCOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-03 DOI: 10.1016/j.ijrobp.2025.10.013
Maria Gebre-Medhin MD, PhD , Gabriel Adrian MD, PhD
{"title":"Circulating Tumor DNA in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma—Are We Ready to Individualize Treatment?","authors":"Maria Gebre-Medhin MD, PhD ,&nbsp;Gabriel Adrian MD, PhD","doi":"10.1016/j.ijrobp.2025.10.013","DOIUrl":"10.1016/j.ijrobp.2025.10.013","url":null,"abstract":"","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"124 3","pages":"Pages 686-691"},"PeriodicalIF":6.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Regard to Duan et al 关于Duan等人
IF 6.5 1区 医学 Q1 ONCOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-03 DOI: 10.1016/j.ijrobp.2025.11.027
Masamune Noguchi MD, Kenta Nimura MD, Yutaro Koide MD, PhD
{"title":"In Regard to Duan et al","authors":"Masamune Noguchi MD,&nbsp;Kenta Nimura MD,&nbsp;Yutaro Koide MD, PhD","doi":"10.1016/j.ijrobp.2025.11.027","DOIUrl":"10.1016/j.ijrobp.2025.11.027","url":null,"abstract":"","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"124 3","pages":"Pages 881-882"},"PeriodicalIF":6.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Regard to Ka et al. 关于Ka等人。
IF 6.5 1区 医学 Q1 ONCOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-03 DOI: 10.1016/j.ijrobp.2025.11.014
Matthias May MD, PhD, Oscar R. Brouwer MD, PhD, Laura Elst MD, Maarten Albersen MD, PhD
{"title":"In Regard to Ka et al.","authors":"Matthias May MD, PhD,&nbsp;Oscar R. Brouwer MD, PhD,&nbsp;Laura Elst MD,&nbsp;Maarten Albersen MD, PhD","doi":"10.1016/j.ijrobp.2025.11.014","DOIUrl":"10.1016/j.ijrobp.2025.11.014","url":null,"abstract":"","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"124 3","pages":"Pages 868-869"},"PeriodicalIF":6.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Regard to Choi et al In Regard to Choi等人
IF 6.5 1区 医学 Q1 ONCOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-03 DOI: 10.1016/j.ijrobp.2025.11.019
Jean-Michel Hannoun-Levi MD, PhD, Cristina Gutierrez MD, PhD, Vratislav Strnad MD, PhD, Csaba Polgar MD, PhD
{"title":"In Regard to Choi et al","authors":"Jean-Michel Hannoun-Levi MD, PhD,&nbsp;Cristina Gutierrez MD, PhD,&nbsp;Vratislav Strnad MD, PhD,&nbsp;Csaba Polgar MD, PhD","doi":"10.1016/j.ijrobp.2025.11.019","DOIUrl":"10.1016/j.ijrobp.2025.11.019","url":null,"abstract":"","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"124 3","pages":"Pages 874-875"},"PeriodicalIF":6.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Radiation Oncology Biology Physics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1